Milestone Pharmaceuticals Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
MIST Nasdaq 2830 www.milestonepharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals (MIST) Stock Sees Fair Value Falls As Analysts Reset Cardamyst Expectations - Oct 23rd, 2026 2:13 am
Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences - Oct 19th, 2026 6:00 am
Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial - Oct 9th, 2026 6:00 am
Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR - Sep 24th, 2026 6:00 am
Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States - Sep 3rd, 2026 7:35 am
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences - Sep 2nd, 2026 6:00 am
Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes - Aug 27th, 2026 6:00 am
Milestone Pharmaceuticals shares rise as first patient enters Phase 3 AFib trial - Aug 21st, 2026 7:28 am
Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR) - Aug 21st, 2026 6:00 am
Milestone Pharmaceuticals Inc. Q2 2026 Earnings Call Summary - Aug 12th, 2026 7:39 pm
Milestone Pharmaceuticals Q2 Earnings Call Highlights - Aug 12th, 2026 9:04 am
Milestone Pharmaceuticals (MIST) Reports Q2 Loss, Lags Revenue Estimates - Aug 12th, 2026 6:25 am
Milestone Pharmaceuticals shares tumble after Q2 earnings miss - Aug 12th, 2026 6:04 am
Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update - Aug 12th, 2026 5:08 am
Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026 - Aug 4th, 2026 2:01 pm
After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Milestone Pharmaceuticals (MIST) - Jul 29th, 2026 7:35 am
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jul 2nd, 2026 7:30 pm
Milestone (MIST) Q1 2026 Earnings Transcript - Jun 1st, 2026 8:31 am